AngioDynamics, Inc. (NASDAQ:ANGO – Free Report) – Research analysts at Zacks Research dropped their Q3 2028 EPS estimates for shares of AngioDynamics in a report issued on Tuesday, August 4th. Zacks Research also issued estimates for AngioDynamics’ FY2029 earnings at ($0.15) EPS. The medical instruments supplier reported ($0.07) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.11) by $0.04. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of AngioDynamics in a research note on Friday, July 17th. Weber Capital Management LLC ADV purchased a new stake in shares of AngioDynamics during the fourth quarter worth about $17,978,000.